Copyright
©The Author(s) 2025.
World J Clin Cases. Oct 26, 2025; 13(30): 110820
Published online Oct 26, 2025. doi: 10.12998/wjcc.v13.i30.110820
Published online Oct 26, 2025. doi: 10.12998/wjcc.v13.i30.110820
Table 1 Patient’s laboratory findings
May 26, 2022 (initial presentation) | Day 1 (August 24, 2022) | Day 2 (August 25, 2022) | Day 3 (August 26, 2022) | Day 4 (August 27, 2022) | Day 5 (August 28, 2022) | |
Hemoglobin (Reference: 12-16 g/dL) | 10.6 | 10.0 | 10.5 | |||
Mean corpuscular volume (Reference: 78-96 fL) | 93 | 92 | 91 | |||
Sodium (Reference: 135-145 mmol/L) | 138 | 135 | 132 | 135 | 134 | |
Potassium (Reference: 3.5-5.0 mmol/L) | 3.5 | 4.9 | 3.5 | 3.2 | 3.4 | |
Chloride (Reference: 98-107 mmol/L) | 112 | |||||
Potential of hydrogen | 7.28 | 6.97 | 7.21 | 7.36 | 7.42 | |
Bicarbonate (Reference 22-28 mEq/L) | 12.0 | 2.0 | 5.1 | 12.8 | 20.3 | |
Partial pressure of carbon dioxide (Reference: 35-45 mmHg) | 30.0 | 8.9 | 12.7 | 22.3 | 31.1 | |
Partial pressure of oxygen (Reference: 75 to 100 mmHg) | 43 | |||||
Creatinine (Reference: 0.6-1.2 mg/dL) | 1.00 | 6.02 | 3.21 | 4.15 | 4.92 | |
Urea (Reference: 7-20 mg/dL) | 33 | 109 | 62 | 79 | 93 | |
Serum ketones (Reference: Negative) | Positive | |||||
C-reactive protein (Reference: < 0.5 mg/dL) | 0.43 | 1.21 | 4.54 | 4.59 | 5.18 | |
Procalcitonin (Reference: Up to 0.5 ng/dL) | 1.03 | 0.34 | ||||
Lactate dehydrogenase (Reference: 60-248 U/L) | 327 | 309 | 358 | |||
Venous lactic acid (Reference: 4.5-19.8 mg/dL) | 27 | |||||
Amylase (Reference: 0-120 U/L) | 412 | 1377 | 986 | |||
Lipase (Reference: 10-55 U/L) | 3360 | |||||
Alanine aminotransferase (Reference: 0-40 U/L) | 25 | 23 | ||||
Aspartate aminotransferase (Reference: 0-40 U/L) | 27 | 35 | ||||
Albumin (Reference: 3.2-5.0 g/dL) | 3.4 | 2.9 | 2.8 | |||
Globulin (Reference: 2.7-3.3 g/dL) | 2.5 | 1.7 | 1.9 | |||
Total proteins (Reference: 6.4-8.3 g/dL) | 5.9 | 4.6 | 4.7 | |||
Prothrombin time (Reference: 11-15 Seconds) | 17.8 | |||||
Partial thromboplastin time (Reference: 25-40 Seconds) | ||||||
International normalized ratio (Reference: 0.8-1.2) | 3.4 | 1.53 | ||||
Lactate level (Reference: 0.5-2.2 mmol/L) | 9.5 |
Table 2 Patient’s laboratory findings
Day 6 (August 29, 2022) | Day 7 (August 30, 2022) | Day 8 (August 31, 2022) | Day 11 (September 3, 2022) | Day 19 (September 11, 2022) | |
Amylase (Reference: 0-104 U/L) | 410 | 342 | 228 | ||
Creatinine (Reference: 0.6-1.2 mg/dL) | 5.32 | 5.53 | 5.77 | 2.99 | 0.75 |
Urea (Reference: 7-20 mg/dL) | 96 | 90 | 91 | 63 | 17 |
Alanine transaminase (Reference: 0-40 U/L) | 753 | 1186 | 775 | 204 | 35 |
Aspartate aminotransferase (Reference: 0-40 U/L) | 297 | 17 | |||
Bilirubin (Total, direct) (Reference: Total 2.0-1.2 mg/dL, direct 0-0.3 mg/dL) | Total: 1.16; Direct: 0.94 | ||||
Albumin (Reference: 3.2-5.0 g/dL) | 135.0 | 3.6 | |||
Globulin (Reference: 2.7-3.3 g/dL) | 3.6 | ||||
Total proteins (Reference: 6.4-8.3 g/dL) | 4.6 | ||||
Prothrombin time (Reference: 11-15 Seconds) | 34.9 | 19.7 | 17.7 | ||
Partial thromboplastin time (Reference: 25-40 Seconds) | 39 | 37 | 32 | ||
International normalized ratio (Reference: 0.8-1.2) | 3.40 | 1.73 | 1.52 | ||
Bicarbonate (Reference 22-28 mEq/L) | |||||
Partial pressure of oxygen (Reference: 75-100 mmHg) | |||||
C-reactive protein (Reference: < 0.5 mg/dL) | 4.52 | 4.49 | 1.13 | ||
Procalcitonin (Reference: Up to 0.5 ng/dL) | 71.2 | 33.6 | |||
Sodium (Reference: 135-145 mmol/L) | 135.0 | 133.0 | 133.0 | 146.6 | |
Potassium (Reference: 3.5-5.0 mmol/L) | 3.90 | 3.70 | 2.64 | 4.57 |
- Citation: AlKhateb B, Alkhateb O, Daaboul B. Metformin abuse and weight loss: A case report. World J Clin Cases 2025; 13(30): 110820
- URL: https://www.wjgnet.com/2307-8960/full/v13/i30/110820.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i30.110820